FUNQOLR (FUNctional and QOL changes with Recurrent OPC)

  • Research type

    Research Study

  • Full title

    Changes to function and quality of life and patient experience for patients undergoing treatments for recurrent oropharyngeal cancer

  • IRAS ID

    297893

  • Contact name

    Grainne Brady

  • Contact email

    grainne.brady@nhs.net

  • Sponsor organisation

    The Royal Marsden NHS Foundation Trust

  • Clinicaltrials.gov Identifier

    NCT04952922

  • Clinicaltrials.gov Identifier

    NA, NA

  • Duration of Study in the UK

    1 years, 6 months, 0 days

  • Research summary

    Oropharyngeal cancer (OPC), is a type of head and neck cancer involving the tonsils and back of the tongue. Treatments include radiotherapy, chemotherapy and surgery. OPC can have a great impact on communication and swallowing and subsequent quality of life (QOL). The overall cure rate remains poor, with disease returning in approximately 20-30% of patients. When the disease comes back, it is very difficult to treat. Usually, the only option which may offer cure is surgery or a second course of radiotherapy both of which can cause even more difficulty with swallowing, communication speech and overall QOL. Sometimes curative treatment options are not possible if the person is too unwell, the tumour is too big or if the impact on swallowing and communication is predicted to be too great. People are offered palliative treatments aiming not to cure but to slow down tumour growth and to keep the person comfortable. Patients often have to make very difficult decisions choosing between potential cure and changes to function and quality of life however, the functional and quality of life outcomes are not well understood for any of the available treatments for recurrent OPC including curative and non-curative options. This study will investigate changes in function (swallowing and communication) and quality of life over time in people with recurrent OPC through an observational study using (1) patient-reported questionnaires (2) clinician-reported rating scales and (3) an assessment of swallowing using a small camera/ scope placed in the throat (via the nose). Interviews with patients and their carers will also be undertaken to investigate patient and carer experience of functional and quality of life changes.

  • REC name

    South Central - Hampshire B Research Ethics Committee

  • REC reference

    21/SC/0303

  • Date of REC Opinion

    27 Oct 2021

  • REC opinion

    Further Information Favourable Opinion